Mechanism of Action Stimulates angiogenesis (formation of new blood vessels) Increases fibroblast activity and collagen synthesis Reduces pro-inflammatory cytokines and promotes anti-inflammatory cascades Enhances tendon-to-bone healing , muscle fiber regeneration, and gut lining repair Works through interaction with the nitric oxide system , aiding circulation and tissue oxygenation BPC157 promotes tendon and ligament healing, accelerates wound closure, and stabilizes vascular response after injury. Sikiric et al., Current Pharmaceutical Design Applications Joint pain, tendonitis, ligament tears Ulcers, IBS, leaky gut Muscle strain, post-surgical recovery Neural repair and recovery from nerve compression Post-cycle inflammation and tissue stress Delivery Administered via subcutaneous injection , near site of injury or systemically Can also be taken orally for GI-related issues (due to gastric stability) MK677 (Ibutamoren) Overview and How It Works MK677 (Ibutamoren) is an orally active growth hormone secretagogue that mimics the action of ghrelin to stimulate the release of growth hormone (GH) and IGF1

It is cost-effective and effective for treating common B12 deficiencies
Its stability profile, multi-pathway interactions, most robustly demonstrated through the nitric oxide and VEGF signalling systems, and broad applicability across connective tissue biology, gastrointestinal research, angiogenesis studies, neurobiology, and inflammation research make it a genuinely versatile and valuable research tool
The "Typical dose" column lists the dose most commonly cited in community protocols
Subcutaneous injection basics Glow peptide is administered subcutaneously, meaning into the fatty tissue layer just beneath the skin
It does not matter for B12 injections, which bypass the digestion process and directly enter the bloodstream